Search the RE article base
Contact Information
Twitter
My TweetsUseful Web Sites
Author Archives: Gerald Barnett
Five Steps to Restoring an Effective University IP Practice, Step 3
We are working through five steps to restoring your university IP practice to something effective and conscionable. The third step involves a fundamental, but again simple, change in policy. Current IP policy at most universities does not address non-exclusive and … Continue reading
Posted in Freedom, Policy
Tagged exclusive, management, patent
Comments Off on Five Steps to Restoring an Effective University IP Practice, Step 3
Five Steps to Restoring an Effective University IP Practice, Steps 1 and 2
Over the past couple of years, I have been involved in projects based on the idea of commons for the exchange of research and diagnostic assets. These projects have been blocked or resisted at each point by organizational technology transfer … Continue reading
Latkerstein’s Monster, 2
The monopoly meme argument is that no one would have ever received any cisplatin if not for an exclusive license to motivate a big drug company to “develop” the drug as a product. Left out is the idea that the … Continue reading
Latkerstein’s Monster, 1
I ran a Twitter thread on this topic. Here’s more of the same. The Bayh-Dole Coalition describes Bayh-Dole as part of a “delicate balance of the university techtransfer system.” My experience differs. There is no “delicate balance.” Bayh-Dole is a … Continue reading
Nicotine Patches, 4
Let’s review where we have got to in this dive into the history of nicotine patches. The UC did not transfer technology in the nicotine patch case. Ciba-Geigy did not need the UC technology–it seems to have wanted the patent … Continue reading
Posted in Bayh-Dole, Technology Transfer
Tagged Alza, Ciba-Geigy, nicotine, patch, replacement therapy
Comments Off on Nicotine Patches, 4
Nicotine Patches, 3
Now for the University of California, Los Angeles. The Association of University Technology Managers (AUTM) wrote up the UC nicotine patch story with the headline “Turning Quitters Into Winners: The Nicotine Patch Success Story” as part of their “Better World … Continue reading
Posted in Bayh-Dole, Technology Transfer
Tagged nicotine patch, replacement therapy, UCLA, University of California
Comments Off on Nicotine Patches, 3
Nicotine Patches, 2
We are working through the history of nicotine patches, to learn what we can from UC’s claim to have invented the nicotine patch, and AUTM’s claim that this is a success story, and the Bayh-Dole Coalition’s claim that this success … Continue reading
Posted in Technology Transfer
Tagged Alza, Etscorn, Nicorette, Pharmetrix
Comments Off on Nicotine Patches, 2
Nicotine Patches, 1
The Bayh-Dole Coalition recently posted on Twitter a claim that the development of the nicotine patch was a Bayh-Dole “success story”: Bayh-Dole Success Story! Did you know that the nicotine patch was developed at @UCLA and commercialized via Bayh-Dole? Check … Continue reading
Posted in Bayh-Dole
Tagged Alza, nicotine, patch, technology transfer, University of California
Comments Off on Nicotine Patches, 1
Why the NIH fuss with Moderna over inventorship doesn’t matter, but does
The New York Times ran a story today that Moderna and the NIH are having a spat over inventorship on a patent application covering aspects of the Moderna mRNA vaccine. The N.I.H. had been in talks with Moderna for more … Continue reading
How they screwed over Senator Long and inventors after Bayh-Dole
The miracle of Bayh-Dole came about, so the story is told, because Senator Long, the arch-critic of Bayh-Dole (“the worst bill I’ve seen in my life”), suddenly flipped his position to give Senator Bayh a consolation gift for losing his … Continue reading